...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: A new mission for the future sale of Zenith

...to keep RVX afloat for another year; per todays RVX AGM?

Share
New Message
Please login to post a reply